HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
50,400
-100 (-0.20%)
At close: Feb 27, 2026

HansBiomed Balance Sheet

Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Equivalents
15,9178,1497,2596,1327,5247,051
Trading Asset Securities
---916.266,03013,217
Cash & Short-Term Investments
15,9178,1497,2597,04813,55320,268
Cash Growth
187.36%12.26%3.00%-48.00%-33.13%-11.35%
Accounts Receivable
19,71416,64611,24612,0919,5617,337
Other Receivables
804.64595.04646.92779.81459.592,388
Receivables
22,05217,28011,93312,90310,2239,803
Inventory
29,68828,83328,34227,79826,93618,673
Prepaid Expenses
-794.65557.28733.24579.89433.2
Other Current Assets
2,9981,0151,6161,9113,0791,935
Total Current Assets
70,65556,07249,70750,39354,37151,113
Property, Plant & Equipment
41,74641,72443,52344,23446,93446,591
Long-Term Investments
5,4935,7285,2624,3566,2228,926
Other Intangible Assets
467.16535.75794.97755.83899.81,031
Long-Term Accounts Receivable
2,9702,375236.810--
Long-Term Deferred Tax Assets
328.57328.572,2022,3182,636734.37
Long-Term Deferred Charges
-----89.19
Other Long-Term Assets
19,50419,58819,78820,13220,46420,756
Total Assets
141,211126,407121,715122,368131,686129,445
Accounts Payable
4,6055,3992,2742,1141,9841,204
Accrued Expenses
1,9091,4591,096947.38841.76743.93
Short-Term Debt
35,30035,30034,30039,45053,55327,300
Current Portion of Long-Term Debt
-----9,000
Current Portion of Leases
794.76807.331,130942.131,010740.52
Current Income Taxes Payable
303.92509.95848.17109.47320.37-
Other Current Liabilities
17,92737,56010,44521,69116,73422,002
Total Current Liabilities
60,84081,03450,09265,25374,44360,991
Long-Term Debt
6,0006,000---12,879
Long-Term Leases
1,0771,1991,000749.261,3471,658
Other Long-Term Liabilities
2,3924,2873,5016,4178,4416,336
Total Liabilities
70,30992,52154,59372,41984,23181,863
Common Stock
7,1216,7636,7636,0585,0515,051
Additional Paid-In Capital
112,04782,22482,22458,62132,28832,288
Retained Earnings
-44,268-46,323-14,982-7,75915,2869,139
Treasury Stock
--5,833-5,833-5,833-5,055-884.32
Comprehensive Income & Other
-3,981-3,127-1,298-1,958-1,937-1,143
Total Common Equity
70,91933,70466,87449,12945,63444,451
Minority Interest
-17.18182.7248.39819.761,8213,130
Shareholders' Equity
70,90233,88767,12249,94947,45547,581
Total Liabilities & Equity
141,211126,407121,715122,368131,686129,445
Total Debt
43,17243,30736,43041,14155,91051,577
Net Cash (Debt)
-27,255-35,158-29,171-34,093-42,356-31,309
Net Cash Per Share
-2083.61-2707.17-2252.56-3181.12-3224.39-3127.17
Filing Date Shares Outstanding
13.3512.9912.9911.589.6410.01
Total Common Shares Outstanding
13.3512.9912.9911.589.6410.01
Working Capital
9,816-24,963-385.31-14,860-20,072-9,878
Book Value Per Share
5313.952595.205149.324243.814732.034439.82
Tangible Book Value
70,45233,16866,07948,37344,73443,420
Tangible Book Value Per Share
5278.952553.955088.104178.524638.724336.84
Land
12,57112,57112,45912,54212,52512,525
Buildings
22,08622,08621,92522,04917,64918,110
Machinery
22,67222,40220,99819,8698,9207,919
Construction In Progress
2,0031,4291,5351,2621,0431,603
Source: S&P Global Market Intelligence. Standard template. Financial Sources.